Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Menozzi-Arnaud M"'
Autor:
Ko M; MMGH Consulting GmbH, 1211 Geneva, Switzerland., Frivold C; PATH, Seattle, WA 98121, USA., Mvundura M; PATH, Seattle, WA 98121, USA., Soble A; MMGH Consulting GmbH, 1211 Geneva, Switzerland., Gregory C; UNICEF, New York, NY 10038, USA., Christiansen H; UNICEF, 2100 Copenhagen, Denmark., Hasso-Agopsowicz M; World Health Organization, 1211 Geneva, Switzerland., Fu H; London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK., Jit M; London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.; School of Public Health, The University of Hong Kong, Hong Kong SAR 999077, China., Hsu S; PATH, Seattle, WA 98121, USA., Mistilis JJ; PATH, Seattle, WA 98121, USA., Scarna T; Gavi, The Vaccine Alliance, 1211 Geneva, Switzerland., Earle K; The Bill and Melinda Gates Foundation, Seattle, WA 98121, USA., Menozzi-Arnaud M; Gavi, The Vaccine Alliance, 1211 Geneva, Switzerland., Giersing B; World Health Organization, 1211 Geneva, Switzerland., Jarrahian C; PATH, Seattle, WA 98121, USA., Yakubu A; UNICEF, New York, NY 10038, USA., Malvolti S; MMGH Consulting GmbH, 8049 Zurich, Switzerland., Amorij JP; UNICEF, 2100 Copenhagen, Denmark.
Publikováno v:
Vaccines [Vaccines (Basel)] 2024 Sep 19; Vol. 12 (9). Date of Electronic Publication: 2024 Sep 19.
Autor:
Soble A; MMGH Consulting GmbH, Geneva, Switzerland. Electronic address: soblea@mmglobalhealth.org., Ko M; MMGH Consulting GmbH, Geneva, Switzerland. Electronic address: kom@mmglobalhealth.org., Gilchrist S; MMGH Consulting GmbH, Toronto, Canada. Electronic address: shawngilchrist@sympatico.ca., Malvolti S; MMGH Consulting GmbH, Zürich, Switzerland. Electronic address: malvoltis@mmglobalhealth.org., Hasso-Agopsowicz M; Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland. Electronic address: hassoagopsowiczm@who.int., Giersing B; Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland. Electronic address: giersingb@who.int., Amorij JP; Supply Division, Vaccine Centre, UNICEF, Copenhagen, Denmark. Electronic address: jamorij@unicef.org., Jarrahian C; PATH, Seattle, WA, United States. Electronic address: cjarrahian@path.org., El Sheikh F; Gavi, The Vaccine Alliance, Geneva, Switzerland. Electronic address: felsheikh@gavi.org., Menozzi-Arnaud M; Gavi, The Vaccine Alliance, Geneva, Switzerland. Electronic address: mmenozziarnaud@gavi.org., Scarna T; Gavi, The Vaccine Alliance, Geneva, Switzerland. Electronic address: tscarna@gavi.org.
Publikováno v:
Vaccine [Vaccine] 2024 Feb 27; Vol. 42 (6), pp. 1230-1246. Date of Electronic Publication: 2024 Feb 06.
Autor:
Malvolti S; MMGH Consulting GmbH, Zurich, Switzerland., Ko M; MMGH Consulting GmbH, Zurich, Switzerland., Menozzi-Arnaud M; Gavi, The Vaccine Alliance, Geneva, Switzerland., Mantel C; MMGH Consulting GmbH, Zurich, Switzerland., Jarrahian C; PATH, Seattle, WA, United States., Amorij JP; Supply Division, Vaccine Centre, UNICEF, Copenhagen, Denmark., Giersing B; Immunisation, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Hasso-Agopsowicz M; Immunisation, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Publikováno v:
Frontiers in public health [Front Public Health] 2023 Jun 12; Vol. 11, pp. 1165110. Date of Electronic Publication: 2023 Jun 12 (Print Publication: 2023).
Autor:
Scarnà T; Gavi, the Vaccine Alliance, Geneva, Switzerland., Menozzi-Arnaud M; Gavi, the Vaccine Alliance, Geneva, Switzerland., Friede M; World Health Organization, Geneva, Switzerland., DeMarco K; Biomedical Advanced Research and Development Authority, Seattle, Washington DC, USA., Plopper G; Biomedical Advanced Research and Development Authority, Seattle, Washington DC, USA., Hamer M; Congressionally Directed Medical Research Programs, Fort Detrick, Maryland, USA.; Department of Emergency Medicine, George Washington University School of Medicine and Health Sciences, Seattle, Washington DC, USA.; Department of Military and Emergency Medicine, Uniformed Services University, Bethesda, MD, USA., Chakrabarti A; Bill & Melinda Gates Foundation, Seattle, Washington DC, USA., Gilbert PA; Bill & Melinda Gates Foundation, Seattle, Washington DC, USA., Jarrahian C; PATH, Seattle, Washington DC, USA., Mistilis J; PATH, Seattle, Washington DC, USA., Hesselink R; Coalition for Epidemics Preparedness Innovations (CEPI), Oslo, Norway., Gandrup-Marino K; United Nations Children's Fund (UNICEF), Copenhagen, Denmark., Amorij JP; United Nations Children's Fund (UNICEF), Copenhagen, Denmark., Giersing B; World Health Organization, Geneva, Switzerland.
Publikováno v:
Expert opinion on drug delivery [Expert Opin Drug Deliv] 2023 Mar; Vol. 20 (3), pp. 315-322. Date of Electronic Publication: 2023 Jan 27.
Autor:
Ko M; MMGH Consulting GmbH, Geneva, Switzerland., Malvolti S; MMGH Consulting GmbH, Zurich, Switzerland., Cherian T; MMGH Consulting GmbH, Geneva, Switzerland., Mantel C; MMGH Consulting GmbH, Zurich, Switzerland., Biellik R; Independent Consultant, La Rippe, Switzerland., Jarrahian C; PATH, Seattle, WA, United States., Menozzi-Arnaud M; Gavi, The Vaccine Alliance, Geneva, Switzerland., Amorij JP; Supply Division, Vaccine Centre, UNICEF, Copenhagen, Denmark., Christiansen H; Supply Division, Vaccine Centre, UNICEF, Copenhagen, Denmark., Papania MJ; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA, United States., Meltzer MI; Division of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, Atlanta, GA, United States., Masresha BG; Vaccine Preventable Diseases, World Health Organization Regional Office for Africa (AFRO/WHO), Harare, Zimbabwe., Pastor D; Immunization Unit, Pan American Health Organization (PAHO), Washington, DC, United States., Durrheim DN; Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia., Giersing B; Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Hasso-Agopsowicz M; Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Publikováno v:
Frontiers in public health [Front Public Health] 2023 Jan 16; Vol. 10, pp. 1037157. Date of Electronic Publication: 2023 Jan 16 (Print Publication: 2022).
Autor:
Hasso-Agopsowicz M; Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Crowcroft N; Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Biellik R; Independent, La Rippe, Switzerland., Gregory CJ; Immunization Unit, Programme Division, United Nations Children's Fund (UNICEF), New York, NY, United States., Menozzi-Arnaud M; Gavi, The Vaccine Alliance, Geneva, Switzerland., Amorij JP; Supply Division, Vaccine Centre, UNICEF, Copenhagen, Denmark., Gilbert PA; Vaccine Development and Surveillance, Bill and Melinda Gates Foundation, Seattle, WA, United States., Earle K; Vaccine Development and Surveillance, Bill and Melinda Gates Foundation, Seattle, WA, United States., Frivold C; Medical Devices and Health Technologies, PATH, Seattle, WA, United States., Jarrahian C; Medical Devices and Health Technologies, PATH, Seattle, WA, United States., Mvundura M; Medical Devices and Health Technologies, PATH, Seattle, WA, United States., Mistilis JJ; Medical Devices and Health Technologies, PATH, Seattle, WA, United States., Durrheim DN; Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia., Giersing B; Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Publikováno v:
Frontiers in public health [Front Public Health] 2022 Mar 02; Vol. 10, pp. 809675. Date of Electronic Publication: 2022 Mar 02 (Print Publication: 2022).
Autor:
Mvundura M; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA. Electronic address: mmvundura@path.org., Frivold C; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA. Electronic address: cfrivold@path.org., Janik Osborne A; Gavi, the Vaccine Alliance, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland. Electronic address: aosborne@gavi.org., Soni P; Gavi, the Vaccine Alliance, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland., Robertson J; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA. Electronic address: jrobertson@path.org., Kumar S; PATH, 15th Floor, Dr. Gopal Das Bhawan, 28 Barakhamba Road, Connaught Place, New Delhi 110001, India. Electronic address: sdkumar@path.org., Anena J; PATH, PO Box 7404, Kampala, Uganda. Electronic address: janena@path.org., Gueye A; PATH, Fann Residence, Rue Saint-John Perse Angle F, Dakar, Senegal. Electronic address: agueye@path.org., Menozzi-Arnaud M; Gavi, the Vaccine Alliance, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland. Electronic address: mmenozziarnaud@gavi.org., Giersing B; Vaccine Product & Delivery Research, Immunisation, Vaccines and Biologicals, World Health Organization, CH-1211 Geneva 27, Switzerland. Electronic address: giersingb@who.int., Kahn AL; Vaccine Product & Delivery Research, Immunisation, Vaccines and Biologicals, World Health Organization, CH-1211 Geneva 27, Switzerland. Electronic address: kahna@who.int., Scarna T; Gavi, the Vaccine Alliance, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland. Electronic address: tscarna@gavi.org., Kristensen D; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA. Electronic address: dkristensen@path.org.
Publikováno v:
Vaccine [Vaccine] 2021 Dec 03; Vol. 39 (49), pp. 7195-7207. Date of Electronic Publication: 2021 Aug 16.
Autor:
Kristensen D; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA. Electronic address: dkristensen@path.org., Giersing B; World Health Organization, Avenue Appia 20, CH-1211 Geneva 27, Switzerland. Electronic address: giersingb@who.int., Hickling J; Working in Tandem Ltd., 23 Rathmore Rd, Cambridge CB1 7AB, UK. Electronic address: julian@workingintandem.co.uk., Kazi F; Independent, Chemin Sous-le-Village 5, 1277, Arnex sur Nyon, Vaud, Switzerland. Electronic address: fatkazi@gmail.com., Scarna T; Gavi, the Vaccine Alliance, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland. Electronic address: tscarna@gavi.org., Kahn AL; World Health Organization, Avenue Appia 20, CH-1211 Geneva 27, Switzerland. Electronic address: kahna@who.int., Hsu V; Bill & Melinda Gates Foundation, 500 5th Ave N, Seattle, WA 98109, USA. Electronic address: Vivian.Hsu@gatesfoundation.org., Gandrup-Marino K; United Nations Children's Fund, Oceanvej 10-12, 2150 Copenhagen, Denmark. Electronic address: kgandrupmarino@unicef.org., Menozzi-Arnaud M; Gavi, the Vaccine Alliance, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland. Electronic address: mmenozziarnaud@gavi.org.
Publikováno v:
Vaccine [Vaccine] 2021 Dec 03; Vol. 39 (49), pp. 7191-7194. Date of Electronic Publication: 2021 Jun 24.
Autor:
Giersing B; World Health Organization, Avenue Appia 20, CH-1211 Geneva 27, Switzerland. Electronic address: giersingb@who.int., Shah N; World Health Organization, Avenue Appia 20, CH-1211 Geneva 27, Switzerland., Kristensen D; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Amorij JP; UNICEF, Oceanvej 10-12, 2150, Copenhagen, Denmark., Kahn AL; World Health Organization, Avenue Appia 20, CH-1211 Geneva 27, Switzerland., Gandrup-Marino K; UNICEF, Oceanvej 10-12, 2150, Copenhagen, Denmark., Jarrahian C; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Zehrung D; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Menozzi-Arnaud M; Gavi, the Vaccine Alliance, Global Health Campus, Chemin du Pommier 40, 1218, Grand-Saconnex, Geneva, Switzerland.
Publikováno v:
Vaccine [Vaccine] 2021 Dec 03; Vol. 39 (49), pp. 7208-7219. Date of Electronic Publication: 2021 Oct 07.
Autor:
Choi, In-Jeong1 (AUTHOR) cij@quadmedicine.com, Cha, Hye-Ran2 (AUTHOR) hrcha@yuhs.ac, Kwon, Danbi1 (AUTHOR) aramkang@quadmedicine.com, Kang, Aram1 (AUTHOR) j.kim@quadmedicine.com, Kim, Ji Seok1 (AUTHOR), Kim, Jooyoung1 (AUTHOR), Choi, Jeong-Eun1 (AUTHOR), Chung, Hyeon Woo2 (AUTHOR), Park, Sunghoon2 (AUTHOR), Shim, Doo Hee2 (AUTHOR), Kim, Tae-Hyun3 (AUTHOR) taehyunk@lgchem.com, Baek, Seung-Ki1 (AUTHOR), Na, Woon-Sung4 (AUTHOR), Lee, Jae Myun2 (AUTHOR) jaemyun@yuhs.ac, Park, Jung-Hwan5 (AUTHOR) jaemyun@yuhs.ac
Publikováno v:
Pharmaceutics. Dec2024, Vol. 16 Issue 12, p1631. 17p.